Advanced cutaneous squamous cell carcinoma requires timely recognition, risk stratification, and coordinated care across dermatology, surgery, oncology, and radiation oncology. This session reviews treatment strategy for high-risk, locally advanced, recurrent, and metastatic disease, including the evolving role of immunotherapy. Practical considerations include staging, referral timing, treatment sequencing, response assessment, and management of complex or immunosuppressed patients.